Abstract. Hydatidiform moles are considered pre-cancerous lesions of gestational trophoblastic neoplasia and are associated with an aberrant immune response. This preliminary study aimed to evaluate the feasibility of measuring the presence of immune cells as potential prognostic markers for hydatidiform moles. + trophoblast cells were highest in the gestational trophoblastic neoplasias (688/1,000 trophoblast cells) and lowest in the partial moles (87/1,000 trophoblast cells). Our results suggest that regulatory T cells may be involved in the progression of complete hydatidiform moles. A larger cohort study is required to assess whether immune cells are effective prognostic markers in gestational trophoblastic diseases.
IntroductionHydatidiform moles (HM) or molar pregnancy is a unique entity among gestational trophoblastic diseases (GTDs), characterized by abnormal proliferation of placental trophoblasts accompanied by an excess of paternal genes. This pathological form of pregnancy persists until the 1st trimester before clinical symptoms become evident (1-4). The incidence of HM is highest in Asian countries and comparatively low in Western countries (5,6). HM appears as complete moles (CM) or partial moles (PM), based on histopathological features and karyotypes that confer the potential for local invasion and widespread metastasis. The level of aggressiveness varies according to mole type; they may lead to persistent disease or post-molar gestational trophoblastic neoplasia (GTN). Thus, HMs are considered the pre-cancerous lesions of GTN (3,7).Most CMs are cytogenetically diploid with a 46XX karyotype. Both sets of chromosomes are of paternal origin, since the CM results from fertilization of an empty ovum by a haploid (23X) spermatozoa; alternatively, dispermic CMs develop from an empty ovum fertilized by two haploid (23X and/or 23Y) spermatozoa. Both types of CMs are totally paternally derived and represent a complete intrauterine allograft in the mother. In contrast to CMs, PMs are generally triploid; PMs retain maternal chromosomes, but also have an excess set of paternal chromosomes. PMs result from fertilization of a normal haploid ovum (23X) by two haploid spermatozoa (3,4,7). In CMs, the complete allograft conceptus is expected to provoke a maternal immune response, with immune cell invasion leading to rejection. PMs may also provoke an altered immune response compared to normal pregnancy (NP), due to the excess paternal genetic material.Ectopic pregnancy (EP) is another type of first trimester abnormal pregnancy. It is the most common early pregnancy